268 related articles for article (PubMed ID: 34638203)
1. [GPCR48 promotes invasion and metastasis by inducing epithelial-mesenchymal transition in hepatocellular carcinoma cells].
Peng QL; Wei SM; Zhang L; Gan LY; Xie Z; Qin J; Zhang Z; Wei JX
Zhonghua Gan Zang Bing Za Zhi; 2021 Sep; 29(9):849-854. PubMed ID: 34638203
[No Abstract] [Full Text] [Related]
2. FoxM1 overexpression promotes epithelial-mesenchymal transition and metastasis of hepatocellular carcinoma.
Meng FD; Wei JC; Qu K; Wang ZX; Wu QF; Tai MH; Liu HC; Zhang RY; Liu C
World J Gastroenterol; 2015 Jan; 21(1):196-213. PubMed ID: 25574092
[TBL] [Abstract][Full Text] [Related]
3. STAT3 cooperates with Twist to mediate epithelial-mesenchymal transition in human hepatocellular carcinoma cells.
Zhang C; Guo F; Xu G; Ma J; Shao F
Oncol Rep; 2015 Apr; 33(4):1872-82. PubMed ID: 25653024
[TBL] [Abstract][Full Text] [Related]
4. LncRNA FUNDC2P4 down-regulation promotes epithelial-mesenchymal transition by reducing E-cadherin expression in residual hepatocellular carcinoma after insufficient radiofrequency ablation.
Zeng J; Cai X; Hao X; Huang F; He Z; Sun H; Lu Y; Lei J; Zeng W; Liu Y; Luo R
Int J Hyperthermia; 2018 Sep; 34(6):802-811. PubMed ID: 29295626
[TBL] [Abstract][Full Text] [Related]
5. CAPZA1 modulates EMT by regulating actin cytoskeleton remodelling in hepatocellular carcinoma.
Huang D; Cao L; Zheng S
J Exp Clin Cancer Res; 2017 Jan; 36(1):13. PubMed ID: 28093067
[TBL] [Abstract][Full Text] [Related]
6. BVES inhibition triggers epithelial-mesenchymal transition in human hepatocellular carcinoma.
Han P; Fu Y; Luo M; He J; Liu J; Liao J; Tian D; Yan W
Dig Dis Sci; 2014 May; 59(5):992-1000. PubMed ID: 24442236
[TBL] [Abstract][Full Text] [Related]
7. Long noncoding RNA TPTE2P1 promotes the migration and invasion of hepatocellular carcinoma.
Liu J; Wang Z; Yin Y; Li N; Ye NY; Bao B; Gu HC
Eur Rev Med Pharmacol Sci; 2019 May; 23(9):3733-3741. PubMed ID: 31114999
[TBL] [Abstract][Full Text] [Related]
8. ECM1 promotes migration and invasion of hepatocellular carcinoma by inducing epithelial-mesenchymal transition.
Chen H; Jia W; Li J
World J Surg Oncol; 2016 Jul; 14(1):195. PubMed ID: 27460906
[TBL] [Abstract][Full Text] [Related]
9. Downregulation of estrogen receptor-α36 expression attenuates metastasis of hepatocellular carcinoma cells.
Wang R; Chen J; Yu H; Wei Z; Ma M; Ye X; Wu W; Chen H; Fu Z
Environ Toxicol; 2022 May; 37(5):1113-1123. PubMed ID: 35044086
[TBL] [Abstract][Full Text] [Related]
10. Ventilagolin Suppresses Migration, Invasion and Epithelial-Mesenchymal Transition of Hepatocellular Carcinoma Cells by Downregulating Pim-1.
Liu Y; Cheng DH; Lai KD; Su H; Lu GS; Wang L; Lv JH
Drug Des Devel Ther; 2021; 15():4885-4899. PubMed ID: 34880599
[TBL] [Abstract][Full Text] [Related]
11. Role of pelitinib in the regulation of migration and invasion of hepatocellular carcinoma cells via inhibition of Twist1.
Lee S; Kang E; Lee U; Cho S
BMC Cancer; 2023 Jul; 23(1):703. PubMed ID: 37495969
[TBL] [Abstract][Full Text] [Related]
12. Long Noncoding RNA AK021443 Promotes Cell Proliferation and Migration by Regulating Epithelial-Mesenchymal Transition in Hepatocellular Carcinoma Cells.
Yang J; Li J; Liu B; Zhang R; Gu F; Zhao J; Cheng S
DNA Cell Biol; 2018 May; 37(5):481-490. PubMed ID: 29638164
[TBL] [Abstract][Full Text] [Related]
13. FOXF2 deficiency promotes hepatocellular carcinoma metastasis by inducing mesenchymal-epithelial transition.
Dou C; Jin X; Sun L; Zhang B; Han M; Li T
Cancer Biomark; 2017 Jul; 19(4):447-454. PubMed ID: 28582850
[TBL] [Abstract][Full Text] [Related]
14. TRIM66 promotes malignant progression of hepatocellular carcinoma by inhibiting E-cadherin expression through the EMT pathway.
Zhang HG; Pan YW; Feng J; Zeng CT; Zhao XQ; Liang B; Zhang WW
Eur Rev Med Pharmacol Sci; 2019 Mar; 23(5):2003-2012. PubMed ID: 30915743
[TBL] [Abstract][Full Text] [Related]
15. Downregulation of UBAP2L Inhibits the Epithelial-Mesenchymal Transition via SNAIL1 Regulation in Hepatocellular Carcinoma Cells.
Ye T; Xu J; Du L; Mo W; Liang Y; Xia J
Cell Physiol Biochem; 2017; 41(4):1584-1595. PubMed ID: 28334716
[TBL] [Abstract][Full Text] [Related]
16. HOXB7 accelerates the malignant progression of hepatocellular carcinoma by promoting stemness and epithelial-mesenchymal transition.
Huan HB; Yang DP; Wen XD; Chen XJ; Zhang L; Wu LL; Bie P; Xia F
J Exp Clin Cancer Res; 2017 Jun; 36(1):86. PubMed ID: 28646927
[TBL] [Abstract][Full Text] [Related]
17. Suppressive effects of microRNA-16 on the proliferation, invasion and metastasis of hepatocellular carcinoma cells.
Wu WL; Wang WY; Yao WQ; Li GD
Int J Mol Med; 2015 Dec; 36(6):1713-9. PubMed ID: 26499886
[TBL] [Abstract][Full Text] [Related]
18. [Effect of lupeol on invasion and metastasis of human hepatoma HepG2 and SK-HEP-1 cells and its mechanism].
Liu BJ; Ning Q; Zhong RL; Xia Z; Jiang ZY; Song J; Wei YJ
Zhongguo Zhong Yao Za Zhi; 2020 Dec; 45(24):6028-6035. PubMed ID: 33496144
[TBL] [Abstract][Full Text] [Related]
19. Increased expression of SLC46A3 to oppose the progression of hepatocellular carcinoma and its effect on sorafenib therapy.
Zhao Q; Zheng B; Meng S; Xu Y; Guo J; Chen LJ; Xiao J; Zhang W; Tan ZR; Tang J; Chen L; Chen Y
Biomed Pharmacother; 2019 Jun; 114():108864. PubMed ID: 30981107
[TBL] [Abstract][Full Text] [Related]
20. Astragaloside IV inhibits metastasis in hepatoma cells through the suppression of epithelial-mesenchymal transition via the Akt/GSK-3β/β-catenin pathway.
Qin CD; Ma DN; Ren ZG; Zhu XD; Wang CH; Wang YC; Ye BG; Cao MQ; Gao DM; Tang ZY
Oncol Rep; 2017 Mar; 37(3):1725-1735. PubMed ID: 28112375
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
